RT Journal Article
SR Electronic
T1 Pay-it-forward to improve influenza vaccine uptake and public engagement among children and older adults in China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.30.21265713
DO 10.1101/2021.10.30.21265713
A1 Wu, Dan
A1 Jin, Chenqi
A1 Bessame, Khaoula
A1 Tang, Fanny Fong-Yi
A1 Ong, Jason J.
A1 Wang, Zaisheng
A1 Xie, Yewei
A1 Jit, Mark
A1 Larson, Heidi J.
A1 Chantler, Tracey
A1 Lin, Leesa
A1 Gong, Wenfeng
A1 Yang, Fan
A1 Jing, Fengshi
A1 Wei, Shufang
A1 Cheng, Weibin
A1 Zhou, Yi
A1 Ren, Nina
A1 Qiu, Shuhao
A1 Bao, Jianmin
A1 Wen, Liufen
A1 Yang, Qinlu
A1 Tian, Junzhang
A1 Tang, Weiming
A1 Tucker, Joseph D.
YR 2021
UL http://medrxiv.org/content/early/2021/11/01/2021.10.30.21265713.abstract
AB Background China has low seasonal influenza vaccination rates among children and older adults. This quasi-experimental pragmatic trial examined the effectiveness of a pay-it-forward intervention on influenza vaccine uptake among children and older adults compared to standard of care (user-paid vaccination) and free vaccination strategies in China. Pay-it-forward is a community-engaged social innovation in which people receive a free influenza vaccination from a local group and are then asked if they would like to donate financially and/or create a postcard message to promote vaccination among future individuals.Methods We iteratively co-created the pay-it-forward intervention with the community through public engagement and a participatory hackathon. We implemented the three study arms in three clinics (rural, suburban, urban) in Guangdong Province, China. A total of 225 children aged between six months and eight years old and 225 older adults (60 years old or above) were recruited into the study. Regression methods were used to compare influenza vaccine uptake (administrative records) and vaccine confidence (self-report) between the three arms.Results Among all participants, 55/150 (36.7%) in the standard of care arm received an influenza vaccine. 111/150 (74.0%) of people in the pay-it-forward arm received an influenza vaccine. 114/150 (76.0%) of people offered free vaccination received an influenza vaccination. Similar trends were observed among children and older adults. The pay-it-forward arm had significantly higher vaccine confidence when compared to the standard of care arm. In the pay-it-forward arm, 107/111 (96.4%) of participants donated money for subsequent vaccinations and 19 of 60 invited (31.7%) created postcard messages.Conclusions Pay-it-forward was effective in improving influenza vaccine uptake and engagement among children and older adults. Our data have implications for pro-social interventions to enhance influenza uptake in the many countries where influenza vaccines are available for a fee.Trial registration ChiCTR2000040048Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR2000040048Clinical Protocols http://www.chictr.org.cn/showproj.aspx?proj=64256 Funding StatementThis work received financial support from Bill & Melinda Gates Foundation (OPP1217240), and the National Institute for Health Research (NIHR200929).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the London School of Hygiene & Tropical Medicine (approval number 19100) and the Zhuhai Center for Disease Control (2020011) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://drive.google.com/file/d/1vXEVpVSi_x_8P8bva58qL_Wqh7u5bRRB/view?usp=sharing